Cerebral ergotism under treatment with ergotamine and ritonavir.
Spiegel
M
M
Departments of Neurology, University Hospital Innsbruck, Austria. michael.spiegel@uibk.ac.at
Schmidauer
C
C
Kampfl
A
A
Sarcletti
M
M
Poewe
W
W
D000328:Adult; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000009:adverse effects*; D004881:Ergotism / Q000175:diagnosis; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D019438:Ritonavir / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D020301:Vasospasm, Intracranial / Q000139:chemically induced* / Q000175:diagnosis
D017320:HIV Protease Inhibitors; D014662:Vasoconstrictor Agents; D019438:Ritonavir; D004878:Ergotamine